MedTrace Logo

Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema

NCT02032238 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-08-11

Study results available
· View outcomes & findings →

Summary

Asses efficacy of navigated laser in reducing the number of anti-VEGF injections as a prospective study using Bevacizumab.

Conditions

  • Clinically Significant Macular Edema

Interventions

DEVICE

laser photocoagulation

Standard bevacizumab Injections will be combined with laser photocoagulation in a pre-defined manner

Sponsors & Collaborators

  • OD-OS GmbH

    lead INDUSTRY

Principal Investigators

  • Ulrike Weber · OD-OS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032238 on ClinicalTrials.gov